Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (7,185,523)	$ (6,170,045)
Adjustments for:
Depreciation and amortization	119,273	186,049
Share-based compensation	729,642	537,492
Gain on loan forgiveness	0	(14,766)
Increase (Decrease) in Operating Capital [Abstract]
Accounts and other receivable	(377,987)	356,339
Prepaid expenses and other current assets	107,832	197,136
Accounts payable and accrued liabilities	(715,499)	17,590
Net cash used in operating activities	(7,322,262)	(4,890,205)
Cash flows from financing activities:
Proceeds from issuance of common shares and warrants	7,717,634	729,387
Proceeds from issuance of Series A-1 preferred shares and warrants	1,540,820	0
Payment for issuance costs of warrants	(23,446)	0
Repayment of debt	0	(29,532)
Net cash provided by financing activities	17,030,898	592,031
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation [Abstract]
Effect of exchange rate changes on cash and cash equivalents	46,216	(25,903)
Net change in cash and cash equivalents	9,754,852	(4,324,077)
Cash and cash equivalents, beginning of year	1,037,320	5,361,397
Cash and cash equivalents, end of year	10,792,172	1,037,320
Series B-1 Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Series B-1 preferred shares	8,340,000	0
Common Stock and Warrants [Member]
Cash flows from financing activities:
Payments for issuance costs of common shares and warrants	(328,953)	(107,824)
Preferred Stock [Member]
Cash flows from financing activities:
Payments for issuance costs of common shares and warrants	$ (215,157)	$ 0